Clinical Trial

Metabolomics in the Diagnosis and Treatment of Asthma in Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-01.
Trial Details
NCT Number NCT07280364
Lead Sponsor I.M. Sechenov First Moscow State Medical University
Conditions Asthma
Enrollment 100 participants
Start Date 2024-03-13
Primary Completion 2026-06 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-01-28